• Nenhum resultado encontrado

An update on breast cancer multigene prognostic tests-emergent clinical biomarkers

N/A
N/A
Protected

Academic year: 2021

Share "An update on breast cancer multigene prognostic tests-emergent clinical biomarkers"

Copied!
12
0
0

Texto

Loading

Imagem

FIGURE 1 | Clinical applications of multigene/protein signatures in breast cancer. Different multigene/protein assays may have distinctive applications
TABLE 2 | Shared genes/proteins between molecular signatures. Oncotype DX 21 genes Mammaprint70 genes Prosigna/PAM5050 genes Endopredict12 genes BCI 7 genes Mammostrat5 proteins IHC4 4 proteins

Referências

Documentos relacionados

The SENTINA study showed that lymph node disease was restricted to the SLNs in 58% of patients who converted from clinically node-positive to clinically node-negative breast

8, 9 Adjuvant chemotherapy has been found to be a strong clinical predictor of weight gain in women with early-stage breast cancer, which is independent of age, nodal status,

Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study,

Posto isto, além do que qualquer uma das sanções previstas na lei 12.318/2010, a aplicação com assiduidade e propaganda da guarda compartilhada pelo judiciário se mostra capaz

Prognostic impact of the lymph node metastatic ratio on 5-year survival of patients with rectal cancer not submitted to preoperative chemoradiation.. Inadequate lymph node

At the outset of the current decade, clinical trials of postoperative (adjuvant) chemotherapy were conducted in patients with stage IB, stage II or stage IIIA cancer.. These trials

O que se lia nos primeiros escritos que procuravam retratar o que havia ocorrido no país após o Quinze de Novembro era um faccionismo orientado por um lado pela